Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Idexx Laboratories becomes NASDAQ-100 member

Idexx Laboratories becomes NASDAQ-100 member

22nd March 2017

Idexx Laboratories has announced its membership of the NASDAQ-100 Index, the world's preeminent large-cap growth index.

The company also became part of the NASDAQ-100 Equal Weighted Index and NASDAQ-100 Ex Technology Index prior to the opening of markets on March 20th, joining a number of other growth-oriented global businesses.

The NASDAQ-100 was established in 1985 and has become the largest non-financial domestic and international securities index listed on the Nasdaq Stock Market, based on market capitalisation.

It is estimated that the aggregate market capitalisation of the index's component companies exceeds $6 trillion (4.81 trillion pounds), with more than $50 billion of investments in exchange-traded products associated with these businesses.

Jonathan Ayers, chairman and chief executive officer of Idexx Laboratories, said: "Becoming a part of the NASDAQ-100 is further acknowledgment of the tremendous growth our company has achieved through innovation focused on pet healthcare technology."

The firm employs more than 7,000 people at present, selling products to customers in over 175 countries.

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801833834-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.